Imatinib vs Lanreotide Acetate
Imatinib vs Lanreotide Acetate: Overview
This comparison examines the pharmacological differences between Imatinib and Lanreotide Acetate.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Pharmacokinetics
Half-life: Imatinib β 18 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O.
Molecular Weight: Imatinib β 493.6030 g/mol.
Type: Imatinib β Small molecule; Lanreotide Acetate β Protein.